Life Sciences Tools & Services Companies By Held By Insiders

Shares Owned By Insiders
Shares Owned By InsidersEfficiencyMarket RiskExp Return
1TEM Tempus AI, Class
63.7
 0.07 
 8.04 
 0.59 
2CDT Conduit Pharmaceuticals
49.11
 0.01 
 8.06 
 0.05 
3AXDX Accelerate Diagnostics
40.6
(0.06)
 4.04 
(0.24)
4CDXC Chromadex Corp
35.39
 0.18 
 9.18 
 1.67 
5BRKR Bruker
31.91
(0.06)
 2.68 
(0.16)
6CSBR Champions Oncology
26.33
 0.05 
 4.51 
 0.23 
7AFJK Aimei Health Technology
22.7
 0.10 
 0.22 
 0.02 
8PSNL Personalis
19.29
(0.04)
 5.89 
(0.26)
9MEDP Medpace Holdings
17.7
 0.00 
 2.94 
 0.00 
10BIO Bio Rad Laboratories
15.57
 0.02 
 2.33 
 0.06 
11NOTV Inotiv Inc
13.47
 0.24 
 7.08 
 1.70 
12PACB Pacific Biosciences of
9.32
 0.12 
 6.73 
 0.78 
13HBIO Harvard Bioscience
7.77
(0.05)
 4.42 
(0.24)
14RGEN Repligen
6.56
 0.05 
 3.10 
 0.14 
15QTRX Quanterix Corp
6.54
 0.02 
 4.04 
 0.10 
16MLAB Mesa Laboratories
5.74
(0.01)
 3.49 
(0.04)
17CGEN Compugen
5.37
(0.07)
 3.42 
(0.24)
18SEER Seer Inc
4.97
 0.24 
 2.87 
 0.68 
19AZTA Azenta Inc
2.72
(0.01)
 2.60 
(0.02)
20SHC Sotera Health Co
2.46
(0.09)
 2.46 
(0.21)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public. Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.